You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Take back control with percutaneous tibial neuromodulation (PTNM). Imagine a future when you worry less about accidents.
WHAT TO EXPECTWho is a
candidate for PTNM?
Individuals with overactive bladder (OAB) who have not responded to conservative therapies — dietary/fluid modifications, timed voiding, bladder training, or pelvic floor exercises. Also, individuals who have tried and failed overactive bladder medications or are not appropriate candidates for them.
STICK
TO IT
Initial treatment consists of 12 weekly sessions and it is critical that you receive them all.
LEARN ABOUT THE FIRST 12 WEEKSMAINTAIN
RESULTS
If PTNM is effective for you, you can continue treatment with maintenance therapy.
LEARN ABOUT ONGOING PTNM